Evidence map›Paper›PMID 36697821›Full record

ArticleNature2023

A Prox1 enhancer represses haematopoiesis in the lymphatic vasculature.

Jan Kazenwadel, Parvathy Venugopal, Anna Oszmiana, John Toubia, Luis Arriola-Martinez, Virginia Panara, Sandra G Piltz, Chris Brown, Wanshu Ma, Andreas W Schreiber and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
9.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Microenvironmental determinants of endothelial cell heterogeneity.Nature reviews. Molecular cell biology · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Jan KazenwadelCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia.ORCID http://orcid.org/0000-0001-6216-3444
Parvathy VenugopalCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia.
Anna OszmianaCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia.
John ToubiaCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia.ORCID http://orcid.org/0000-0002-5135-6504
Luis Arriola-MartinezCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia.ORCID http://orcid.org/0000-0001-9806-0105
Virginia PanaraDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0002-8717-5190
Sandra G PiltzAdelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.ORCID http://orcid.org/0000-0003-3386-8140
Chris BrownUniversity of South Australia, Adelaide, South Australia, Australia.
Wanshu MaCenter for Vascular and Developmental Biology, Feinberg Cardiovascular Research Institute, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Andreas W SchreiberCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia.ORCID http://orcid.org/0000-0002-9081-3405
Katarzyna KoltowskaDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0002-6841-8900
Samir TaoudiEpigenetics and Development Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
Paul Q ThomasAdelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.ORCID http://orcid.org/0000-0002-5002-5770
Hamish S ScottCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia.ORCID http://orcid.org/0000-0002-5813-631X
Natasha L HarveyCentre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia. natasha.harvey@unisa.edu.au.ORCID http://orcid.org/0000-0001-9839-8966
South Australia Pathology · AUSouth Australian Health and Medical Research Institute · AUUniversity of South Australia · AUUppsala University · SENorthwestern University · USThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcriptional enhancer elements are responsible for orchestrating the temporal and spatial control over gene expression that is crucial for programming cell identity during development

Indexed as

Endothelial CellsEnhancer Elements, GeneticHematopoiesisLymphatic VesselsAnimalsGATA2 Transcription FactorHomeodomain ProteinsMiceNFATC Transcription FactorsProspero-Related Homeobox 1 ProteinTranscription FactorsGata2 protein, mouseGATA2 Transcription FactorHomeodomain ProteinsNfatc1 protein, mouseNFATC Transcription FactorsProspero-Related Homeobox 1 ProteinTranscription Factors

Identifiers

PMID36697821
OpenAlexW4317952814

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.